Documents | Pharmalgen for the treatment of bee and wasp venom allergy | Guidance | NICE

Documents

A list of downloadable documents created during development.

Review proposal consultation

Review proposal consultation
Stakeholder matrix ^{PDF 263.55 KB} 31 July 2017
Review proposal paper ^{PDF 282.21 KB} 31 July 2017

Venom anaphylaxis - immunotherapy pharmalgen: final appraisal determination

Venom anaphylaxis - immunotherapy pharmalgen: final appraisal determination information
Venom anaphylaxis - immunotherapy pharmalgen: final appraisal determination document ^{PDF 223.99 KB} 16 December 2011
Venom anaphylaxis - immunotherapy pharmalgen: response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD) ^{PDF 77.33 KB} 16 December 2011
Venom anaphylaxis - immunotherapy pharmalgen: consultee and commentator comments on the ACD
Venom anaphylaxis - immunotherapy pharmalgen: Royal College of Nursing ^{PDF 18.15 KB} 16 December 2011
Venom anaphylaxis - immunotherapy pharmalgen: Royal College of Physicians ^{PDF 94.01 KB} 16 December 2011
Venom anaphylaxis - immunotherapy pharmalgen: Royal College of Paediatrics and Child Health ^{PDF 19.45 KB} 16 December 2011
Venom anaphylaxis - immunotherapy pharmalgen: Royal College of Pathologists ^{PDF 68.15 KB} 16 December 2011
Venom anaphylaxis - immunotherapy pharmalgen: Department of Health ^{PDF 9.82 KB} 16 December 2011
Venom anaphylaxis - immunotherapy pharmalgen: expert comments on the ACD
Venom anaphylaxis - immunotherapy pharmalgen: Austin ^{PDF 27.96 KB} 16 December 2011
Venom anaphylaxis - immunotherapy pharmalgen: Ewan and Krishna ^{PDF 34.58 KB} 16 December 2011
Venom anaphylaxis - immunotherapy pharmalgen: Glaser ^{PDF 28.03 KB} 16 December 2011

Venom anaphylaxis - immunotherapy pharmalgen: appraisal consultation

Venom anaphylaxis - immunotherapy pharmalgen: appraisal consultation
Venom anaphylaxis - immunotherapy pharmalgen: appraisal consultation document information
Venom anaphylaxis - immunotherapy pharmalgen: appraisal consultation - evaluation report
Venom anaphylaxis - immunotherapy pharmalgen: appraisal consultation - overview ^{PDF 171.49 KB} 30 September 2011
Venom anaphylaxis - immunotherapy pharmalgen: appraisal consultation - assessment report ^{PDF 1.75 MB} 30 September 2011
Venom anaphylaxis - immunotherapy pharmalgen: appraisal consultation - consultee and commentator comments on the assessment report
British Society for Allergy & Clinical Immunology ^{PDF 75.09 KB} 30 September 2011
Royal College of Nursing ^{PDF 86.48 KB} 30 September 2011
Royal College of Paediatrics and Child Health ^{PDF 86.48 KB} 30 September 2011
Royal College of Pathologists ^{PDF 49.77 KB} 30 September 2011
Department of Health ^{PDF 71.59 KB} 30 September 2011
NHS East London and the City ^{PDF 100.7 KB} 30 September 2011
Welsh Government ^{PDF 47.59 KB} 30 September 2011
NHS Healthcare Improvement Scotland ^{PDF 39.85 KB} 30 September 2011
Venom anaphylaxis - immunotherapy pharmalgen: appraisal consultation - non-manufacturer submission from the Royal College of Paediatrics and Child Health ^{PDF 25.45 KB} 30 September 2011
Venom anaphylaxis - immunotherapy pharmalgen: appraisal consultation - expert written personal statements
Austin ^{PDF 45.02 KB} 30 September 2011
Brathwaite ^{PDF 41.98 KB} 30 September 2011
Ewan ^{PDF 48.57 KB} 30 September 2011
Glaser ^{PDF 260.79 KB} 30 September 2011
Krishna ^{PDF 36.59 KB} 30 September 2011

Venom anaphylaxis - immunotherapy pharmalgen: assessment report

Venom anaphylaxis - immunotherapy pharmalgen: assessment report ^{PDF 1.39 MB} 22 July 2011

Venom anaphylaxis - immunotherapy pharmalgen: final protocol

Venom anaphylaxis - immunotherapy pharmalgen: final protocol ^{PDF 373.87 KB} 24 December 2010

Venom anaphylaxis - immunotherapy pharmalgen: final scope

Venom anaphylaxis - immunotherapy pharmalgen: final scope ^{PDF 55.05 KB} 30 November 2010

Venom anaphylaxis - immunotherapy pharmalgen: final matrix

Venom anaphylaxis - immunotherapy pharmalgen: final matrix ^{PDF 6.61 KB} 30 November 2010

Venom anaphylaxis - immunotherapy pharmalgen: response to comments on the draft scope

Venom anaphylaxis - immunotherapy pharmalgen: response to comments on the draft scope ^{PDF 104.88 KB} 30 November 2010

Venom anaphylaxis - immunotherapy pharmalgen: response to comments on the provisional matrix

Venom anaphylaxis - immunotherapy pharmalgen: response to comments on the provisional matrix ^{PDF 25.2 KB} 30 November 2010

Appendix B: draft scope for consultation (pre-referral)

Appendix B: draft scope for consultation (pre-referral) ^{PDF 29.1 KB} 22 July 2010

Appendix C: provisional matrix (pre-referral)

Appendix C: provisional matrix (pre-referral) ^{PDF 29.4 KB} 22 July 2010